This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
NZC | Ann: NZC NTA 27-03-2019 $2.97957 | 28/03/19 | 0 | 11 | |||
|
|||||||
NZC | Ann: NZC NTA 26-03-2019 $2.97938 | 27/03/19 | 0 | 21 | |||
|
|||||||
NZC | Ann: NZC NTA 25-03-2019 $2.97918 | 26/03/19 | 0 | 21 | |||
|
|||||||
NZC | Ann: NZC NTA 22-03-2019 $2.97868 | 25/03/19 | 0 | 22 | |||
|
|||||||
NZC | Ann: NZC NTA 21-03-2019 $2.97856 | 22/03/19 | 0 | 25 | |||
|
|||||||
NZC | Ann: NZC NTA 20-03-2019 $2.97839 | 21/03/19 | 0 | 25 | |||
|
|||||||
NZC | Ann: NZC NTA 19-03-2019 $2.97823 | 20/03/19 | 0 | 22 | |||
|
|||||||
NZC | Ann: NZC NTA 18-03-2019 $2.97807 | 19/03/19 | 0 | 712 | |||
|
See All Discussions